Achieving Consensus for Management of Hormone-Sensitive, Low-Volume Metastatic Prostate Cancer in Italy

Metastatic hormone-sensitive prostate cancer (mHSPC) is usually categorized as high- or low-volume disease. This is relevant because low- and high-volume metastatic disease are associated with different outcomes, and thus management of the two forms should differ. Although some definitions have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Verzoni, Elena, Pappagallo, Giovanni, Alongi, Filippo, Arcangeli, Stefano, Francolini, Giulio, Galanti, Daniele, Galli, Luca, Maruzzo, Marco, Rossetti, Sabrina, Siepe, Giambattista, Triggiani, Luca, Zucali, Paolo Andrea, D’Angelillo, Rolando Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321448/
https://www.ncbi.nlm.nih.gov/pubmed/35877222
http://dx.doi.org/10.3390/curroncol29070362

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321448/
https://www.ncbi.nlm.nih.gov/pubmed/35877222
http://dx.doi.org/10.3390/curroncol29070362

Ejemplares similares